LSD reduced symptoms of anxiety in a midstage study published Thursday, paving the way for additional testing and possible medical approval of a psychedelic drug that has been banned in the U.S. for ...
CLEVELAND — Researchers narrowed down what appears to be the correct dosage during a first ever rigorous clinical trial examining LSD as a treatment for generalized anxiety disorder, with results ...
When Palo Alto Historical Association Vice President Rich Green told the nonprofit’s board members that he wanted to do a lecture on the powerful hallucinogen lysergic acid diethylamide, or LSD, they ...
NEW YORK, May 26, 2021 /CNW/ -- MindMed (Nasdaq: MNMD) (NEO: MMED) (DE: MMQ), a leading psychedelic medicine biotech company, announced today the publication of the first pharmacogenetic data on LSD ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results